Claudio Viscoli - Infectious Diseases

Author Information

Claudio Viscoli is affiliated with the Department of Health Sciences at the University of Genoa, and the Infectious Diseases Unit at IRCCS AOU San Martino-IST Teaching Hospital, both located in Genoa, Italy. His work is predominantly focused on infectious diseases, contributing significantly to the understanding and treatment of various infections.

Research Contributions

Claudio Viscoli has made substantial contributions to the field of infectious diseases, particularly in the study of bloodstream infections, fungal diseases, and antibiotic resistance. His research includes studies on non-fermentative gram-negative bloodstream infections, changes in the epidemiology of candidaemia, and the clinical management of infections caused by Enterobacterales. He has also investigated the seroprevalence of HEV infections and the clinical patterns of Trichinella pseudospiralis outbreaks. Viscoli's work is characterized by multicenter studies and collaborations, reflecting a comprehensive approach to epidemiological and clinical research.

Aliases

Claudio Viscoli is also known by variations of his name, including C Viscoli and C. Viscoli.

Publication and Citation Metrics

Metric	Value
Total Citation Count	27,502
H-index	71
Total Paper Count	481

Publications:

Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study

DOI: 10.1186/s12879-021-06496-8

Year: 2021

Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus.

DOI: 10.1093/cid/ciaa1805

Year: 2021

Changing epidemiology of candidaemia: Increase in fluconazole‐resistant Candida parapsilosis

DOI: 10.1111/myc.13050

Year: 2020

Changes in the relative prevalence of candidaemia due to non‐albicans Candida species in adult in‐patients: A systematic review, meta‐analysis and meta‐regression

DOI: 10.1111/myc.13054

Year: 2020

HEV infection in an Italian cohort of HSCT recipients: seroprevalence and infection.

DOI: 10.1016/j.bbmt.2020.03.012

Year: 2020

Second outbreak of Trichinella pseudospiralis in Europe: clinical patterns, epidemiological investigation and identification of the etiological agent based on the western blot patterns of the patients' serum

DOI: 10.1111/zph.12761

Year: 2020

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)

DOI: 10.1093/ofid/ofaa139

Year: 2020

Non-Fermentative Gram-negative Bloodstream Infection in Northern Italy: a Multicenter Cohort Study.

DOI: 10.21203/rs.3.rs-54258/v1

Year: 2020

Trends in the Incidence and Antibiotic Resistance of Enterococcal Bloodstream Isolates: A 7-Year Retrospective Multicenter Epidemiological Study in Italy.

DOI: 10.1089/mdr.2020.0147

Year: 2020

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort.

DOI: 10.1093/jac/dkz353

Year: 2019

Why is MRI Important?

What are the Recent Advances in Serological Testing?

Why is Vaccination Essential?

What Triggers the Inflammatory Response?

How Can We Mitigate Airborne Transmission?

What are Immunodeficiency Disorders?

Why are Drug Targets Important?

Are Vaccines Safe?

What is Schistosomiasis?

What Are Some Success Stories of One Health in Action?

Partnered Content Networks

Relevant Topics